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INTRODUCTION
Sickle Cell Anemia (SCA) is an autosomal recessive hereditary anemia characterized by the presence of
hemoglobin S (Hb S). This disease is caused by a single mutation in the beta-globin gene with a corresponding
amino acid substitution at the sixth position of the beta-globin chain. The easily ability of Hb S to polymerize
in deoxygenated conditions gives rise to abnormal sickled red blood cells (Figure 1) (Rees et al, 2010). Vaso-
occlusion and hemolytic anemia are the major features of this disease, however SCA patients present clinical
and hematologic variability that cannot be only explained by the single mutation in the beta-globin gene.
Others genetic modifiers and environmental effects are important in the clinical phenotype (Steinberg &
Sebastiani, 2012).
The aim of this work was to determine the association between hematological or biochemical parameters
and genetic variants from candidate genes, in SCA patients.
Figure 1 - Peripheral blood smear of a patient with
SCA. The arrows point to two sickled erythrocytes
(Adapted from Rees et al, 2010).
METHODS
Subjects: 26 paediatric SCA patients (mean age of 8.58 years) followed-up in Hospital de Dona Estefânia, in Lisbon.
Hematological or biochemical parameters: Hb S, total Hb, red cell distribution width (RDW), leukocytes, neutrophils, transmembrane reductase,
methemoglobin reductase, serum lactate dehydrogenase (LDH), total bilirubin and reticulocyte count.
Candidate genes: BCL11A, HBA, HBB cluster, HMOX1, eNOS, MTHFR and MPO.
Statistical analysis: Association studies were performed using T test/ ANOVA parametric tests (Hb S, total Hb, RDW, neutrophils, transmembrane
reductase, methemoglobin reductase and reticulocyte count) or Mann-Whitney/Kuskal-Wallis non-parametric tests (total bilirubin, leukocytes and
LDH), all performed with SPSS 22.0 software.
RESULTS
• Association studies between candidate genotypes and hematological or biochemical parameters were performed. 
• The following significant associations were observed (Table 1 and 2, Figure 2 and 3).
• Our results show a significant statistical association between two eNOS single nucleotide polymorphisms (SNPs) and two haemolysis
parameters. Both the rs2070744_TT and the rs1799983_GG genotypes are associated with an increased reticulocyte count (p = 0.02 and 0.01, 
respectively) and higher serum LDH level (p = 0.04 and 0.04, respectively).
CONCLUSIONS
Our findings suggest that polymorphisms in the eNOS gene may act as genetic modifiers of the haemolysis, which could provide utility for the
prediction of increased susceptibility to haemolysis-related complications.
Furthermore, our results reinforce the importance of nitric oxide (NO) bioactivity in SCA. We presume that NO, and possible its precursors such as
L-arginine or L-citrulline, might be used as pharmacological tools to improve the quality of life of these patients.
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 Table 1 - Association between the parameters reticulocyte count and LDH and rs2070744 genotypes 
(TT and CT) at eNOS gene 
Parameters TT CT p-value* 
Reticulocyte count (%) 9.56 ± 3.43 (13) 
 
6.12 ± 2.50 (10) 
 
0.021 
LDH (U/L) 
 
490.00; 410-793 (7) 
 
371.50; 328-451 (4) 0.042 
1T test - Mean ±  standard deviation (n – sample size) 
2Mann-Whitney test - Median; minimum - maximum (n – sample size) 
 
 
Table 2 - Association between the parameters reticulocyte count and LDH and rs1799983 genotypes 
(GG and GT/TT) at eNOS gene 
Parameters GG GT/TT p-value* 
Reticulocyte count (%) 9.20 ± 3.21 (17) 
 
4.53 ± 1.75 (5) 
 
0.011 
LDH (U/L) 
 
490.00; 410-793 (7) 
 
371.50; 328-451 (4) 0.042 
1T test - Mean ±  standard deviation (n – sample size) 
2Mann-Whitney test - Median; minimum - maximum (n – sample size) 
 
 
 
Figure 2 - Box plots of the distribution of reticulocyte count (a) and LDH level (b) in
rs2070744 genotypes (TT and CT) at eNOS gene.
Figure 3 - Box plots of the distribution of reticulocyte count (a) and LDH level (b) in
rs1799983 genotypes (GG and GT/TT) at eNOS gene.
